Kailix Advisors’s Albemarle ALB Stock Holding History

Kailix Advisors’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-36,500	Closed	-$5.16M	–	11
2025 Q4	$5.16M	Sell	36,500 -108,000	-75%	-$12.3M	5.76%	8
2025 Q3	$11.7M	Buy	+144,500	New	+$11.1M	15.95%	2

Other funds holding ALB

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kailix Advisors's ALB Position: Q1 2026 in Review

Kailix Advisors sold out of Albemarle (ALB) in Q1 2026, closing a stake of 36,500 shares — an estimated $5.16M sold.

Kailix Advisors first reported a position in ALB in Q3 2025 and held it in 2 quarters. The position peaked at $11.7M in Q3 2025. 982 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

Kailix Advisors reported no remaining Albemarle position as of Q1 2026 after selling out during the quarter.
Kailix Advisors sold 36,500 Albemarle shares in Q1 2026, an estimated $5.16M.
Kailix Advisors first reported a position in Albemarle in Q3 2025 and held it in 2 quarters.
Kailix Advisors's Albemarle position peaked at $11.7M in Q3 2025.
982 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on Kailix Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.